INS and type 2 diabetes mellitus: Our results showed that eight weeks of mono-therapeutic Se-NPs (0.1 or 0.4 mg/kg) and/or MET alleviate T2DM-induced elevation in the levels of insulin (3-fold) and HOMA-IR with a reduction in beta-cell function (HOMA-β) in rats.